HRP20010845B1 - Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives - Google Patents
Cinnamoylaminoalkyl-substituted benzenesulfonamide derivativesInfo
- Publication number
- HRP20010845B1 HRP20010845B1 HR20010845A HRP20010845A HRP20010845B1 HR P20010845 B1 HRP20010845 B1 HR P20010845B1 HR 20010845 A HR20010845 A HR 20010845A HR P20010845 A HRP20010845 A HR P20010845A HR P20010845 B1 HRP20010845 B1 HR P20010845B1
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- phenyl
- group
- substituted
- halogen
- Prior art date
Links
- 150000008331 benzenesulfonamides Chemical class 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 14
- 229910052736 halogen Inorganic materials 0.000 abstract 8
- 150000002367 halogens Chemical class 0.000 abstract 8
- 229910052739 hydrogen Inorganic materials 0.000 abstract 7
- 239000001257 hydrogen Substances 0.000 abstract 7
- 125000001424 substituent group Chemical group 0.000 abstract 7
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 6
- 229910052760 oxygen Inorganic materials 0.000 abstract 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 5
- -1 cyanoimino Chemical group 0.000 abstract 5
- 239000001301 oxygen Substances 0.000 abstract 5
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006729 (C2-C5) alkenyl group Chemical group 0.000 abstract 1
- 125000006730 (C2-C5) alkynyl group Chemical group 0.000 abstract 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Chemical group 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/53—X and Y not being nitrogen atoms, e.g. N-sulfonylcarbamic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
- C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19923086A DE19923086A1 (de) | 1999-05-20 | 1999-05-20 | Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
PCT/EP2000/004091 WO2000071513A1 (en) | 1999-05-20 | 2000-05-06 | Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
HRP20010845A2 HRP20010845A2 (en) | 2003-04-30 |
HRP20010845A9 HRP20010845A9 (en) | 2010-06-30 |
HRP20010845B1 true HRP20010845B1 (en) | 2010-08-31 |
Family
ID=7908577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20010845A HRP20010845B1 (en) | 1999-05-20 | 2001-11-16 | Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives |
Country Status (30)
Country | Link |
---|---|
US (1) | US6350778B1 (cs) |
EP (1) | EP1183236B1 (cs) |
JP (1) | JP4559640B2 (cs) |
KR (1) | KR100968729B1 (cs) |
CN (1) | CN1243730C (cs) |
AR (1) | AR035625A1 (cs) |
AT (1) | ATE252554T1 (cs) |
AU (1) | AU771675B2 (cs) |
BR (1) | BR0010821B1 (cs) |
CA (1) | CA2374226C (cs) |
CZ (1) | CZ302943B6 (cs) |
DE (2) | DE19923086A1 (cs) |
DK (1) | DK1183236T3 (cs) |
EE (1) | EE04611B1 (cs) |
ES (1) | ES2208342T3 (cs) |
HK (1) | HK1047574B (cs) |
HR (1) | HRP20010845B1 (cs) |
HU (1) | HU229041B1 (cs) |
IL (2) | IL146372A0 (cs) |
ME (1) | MEP41508A (cs) |
MX (1) | MXPA01011725A (cs) |
NO (1) | NO321558B1 (cs) |
PL (1) | PL201560B1 (cs) |
PT (1) | PT1183236E (cs) |
RS (1) | RS50172B (cs) |
RU (1) | RU2242462C2 (cs) |
SK (1) | SK287237B6 (cs) |
TR (1) | TR200103312T2 (cs) |
WO (1) | WO2000071513A1 (cs) |
ZA (1) | ZA200109481B (cs) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10054482A1 (de) | 2000-11-03 | 2002-05-08 | Aventis Pharma Gmbh | Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE10054481A1 (de) | 2000-11-03 | 2002-05-08 | Aventis Pharma Gmbh | Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
CN1237185C (zh) * | 2003-06-04 | 2006-01-18 | 中国科学院上海药物研究所 | Sars冠状病毒3cl蛋白酶三维结构模型与抗sars药物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1443878A1 (de) * | 1963-10-19 | 1968-12-12 | Hoechst Ag | Verfahren zur Herstellung von Benzolsulfonylharnstoffen |
DE1518877A1 (de) * | 1964-10-07 | 1969-01-30 | Hoechst Ag | Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung |
DE1545810A1 (de) * | 1965-05-06 | 1969-12-11 | Hoechst Ag | Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden |
EP0612724A1 (de) * | 1993-02-23 | 1994-08-31 | Hoechst Aktiengesellschaft | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika |
EP0727416A1 (de) * | 1995-02-17 | 1996-08-21 | Hoechst Aktiengesellschaft | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1518816C3 (de) | 1965-03-24 | 1975-05-22 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
US4066639A (en) | 1965-05-06 | 1978-01-03 | Hoechst Aktiengesellschaft | Benzene-sulfonyl semicarbazides and process for preparing them |
DE2413514C3 (de) * | 1974-03-21 | 1982-03-04 | Hoechst Ag, 6000 Frankfurt | N-Acylaminoathylbenzolsulfonyl-N'-methylharnstoffe, Verfahren zu ihrer Herstellung und deren Verwendung |
DE4341655A1 (de) | 1993-12-07 | 1995-06-08 | Hoechst Ag | Aminosubstituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika |
JPH0826995A (ja) * | 1994-07-22 | 1996-01-30 | Nisshin Flour Milling Co Ltd | ベンズイミダゾール誘導体を含有する抗不整脈剤 |
DE19832009A1 (de) | 1998-07-16 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate |
CZ301165B6 (cs) | 1998-09-10 | 2009-11-25 | Sanofi - Aventis Deutschland GmbH | Použití benzensulfonyl(thio)mocovin pro lécení a profylaxi dysfunkcí autonomní nervové soustavy a použití benzensulfonyl(thio)mocovin v kombinaci s beta-receptorovými blokátory |
US6303637B1 (en) * | 1998-10-30 | 2001-10-16 | Merck & Co., Inc. | Heterocyclic potassium channel inhibitors |
US6632836B1 (en) * | 1998-10-30 | 2003-10-14 | Merck & Co., Inc. | Carbocyclic potassium channel inhibitors |
US6194458B1 (en) * | 1998-10-30 | 2001-02-27 | Merck & Co., Inc. | Benzamide potassium channel inhibitors |
-
1999
- 1999-05-20 DE DE19923086A patent/DE19923086A1/de not_active Withdrawn
-
2000
- 2000-05-06 HU HU0201906A patent/HU229041B1/hu not_active IP Right Cessation
- 2000-05-06 SK SK1669-2001A patent/SK287237B6/sk not_active IP Right Cessation
- 2000-05-06 DE DE60006104T patent/DE60006104T2/de not_active Expired - Lifetime
- 2000-05-06 RU RU2001134291/04A patent/RU2242462C2/ru not_active IP Right Cessation
- 2000-05-06 AT AT00938626T patent/ATE252554T1/de active
- 2000-05-06 ES ES00938626T patent/ES2208342T3/es not_active Expired - Lifetime
- 2000-05-06 RS YUP-817/01A patent/RS50172B/sr unknown
- 2000-05-06 AU AU53933/00A patent/AU771675B2/en not_active Ceased
- 2000-05-06 TR TR2001/03312T patent/TR200103312T2/xx unknown
- 2000-05-06 CZ CZ20014149A patent/CZ302943B6/cs not_active IP Right Cessation
- 2000-05-06 EE EEP200100609A patent/EE04611B1/xx not_active IP Right Cessation
- 2000-05-06 WO PCT/EP2000/004091 patent/WO2000071513A1/en active IP Right Grant
- 2000-05-06 JP JP2000619770A patent/JP4559640B2/ja not_active Expired - Fee Related
- 2000-05-06 KR KR1020017014819A patent/KR100968729B1/ko not_active IP Right Cessation
- 2000-05-06 PL PL351751A patent/PL201560B1/pl unknown
- 2000-05-06 DK DK00938626T patent/DK1183236T3/da active
- 2000-05-06 PT PT00938626T patent/PT1183236E/pt unknown
- 2000-05-06 ME MEP-415/08A patent/MEP41508A/xx unknown
- 2000-05-06 BR BRPI0010821-9A patent/BR0010821B1/pt not_active IP Right Cessation
- 2000-05-06 CN CNB008078203A patent/CN1243730C/zh not_active Expired - Fee Related
- 2000-05-06 IL IL14637200A patent/IL146372A0/xx active IP Right Grant
- 2000-05-06 EP EP00938626A patent/EP1183236B1/en not_active Expired - Lifetime
- 2000-05-06 MX MXPA01011725A patent/MXPA01011725A/es active IP Right Grant
- 2000-05-06 CA CA2374226A patent/CA2374226C/en not_active Expired - Fee Related
- 2000-05-19 AR ARP000102388A patent/AR035625A1/es active IP Right Grant
- 2000-05-19 US US09/573,166 patent/US6350778B1/en not_active Expired - Lifetime
-
2001
- 2001-11-06 IL IL146372A patent/IL146372A/en not_active IP Right Cessation
- 2001-11-16 ZA ZA200109481A patent/ZA200109481B/xx unknown
- 2001-11-16 HR HR20010845A patent/HRP20010845B1/xx not_active IP Right Cessation
- 2001-11-19 NO NO20015636A patent/NO321558B1/no not_active IP Right Cessation
-
2002
- 2002-11-29 HK HK02108646.9A patent/HK1047574B/zh not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1443878A1 (de) * | 1963-10-19 | 1968-12-12 | Hoechst Ag | Verfahren zur Herstellung von Benzolsulfonylharnstoffen |
DE1518877A1 (de) * | 1964-10-07 | 1969-01-30 | Hoechst Ag | Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung |
DE1545810A1 (de) * | 1965-05-06 | 1969-12-11 | Hoechst Ag | Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden |
EP0612724A1 (de) * | 1993-02-23 | 1994-08-31 | Hoechst Aktiengesellschaft | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika |
EP0727416A1 (de) * | 1995-02-17 | 1996-08-21 | Hoechst Aktiengesellschaft | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200600527A1 (ru) | Активирующее ppar соединение и содержащая его фармацевтическая композиция | |
RU2002135308A (ru) | Производные (тио) мочевины, ингибирующие фактор viiа, их получение и применение | |
CA2616580A1 (en) | Macrocyclic inhibitors of hepatitis c virus | |
AR080803A1 (es) | Derivados de 3,4-dihidro-1h-benzo[b][1,6]naftiridina, composiciones farmaceuticas que los contiene, procedimiento para prepararlos e intermediarios del mismo, y uso de los compuestos en el tratamiento de canceres y enfermedades autoinmunes e inflamatorias. | |
RS52061B (en) | PIRAZOLYL-AMINOPYRIDINE DERIVATIVES USEFUL AS KINASE INHIBITORS | |
EA200800737A1 (ru) | Поперечно связанные соединения циклических аминов и средства для борьбы с вредителями | |
NO20064175L (no) | Heterosyklisk forbindelse | |
MX2007008308A (es) | Derivados de n-(heteroaril)-1h-indol-2-carboxamidas y su utilizacion como ligandos del receptor vaniloide trpv1-. | |
AR078833A1 (es) | Derivados de heteroarilos que contienen nitrogeno como inhibidores dela cinasa jak3 | |
AR093725A1 (es) | Quinazolincarboxamida azetidinas | |
AR068538A1 (es) | Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido | |
WO2009041447A1 (ja) | 5員複素環化合物 | |
EA201070876A1 (ru) | Трициклические соединения, обладающие антагонистической активностью по отношению к кортикотропин-высвобождающему фактору, и содержащие их фармацевтические композиции | |
UY28127A1 (es) | Nuevos enantiomeros (r) y (s) de derivados del acido tiofeno hidroxamico | |
DK0759027T3 (da) | Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase | |
AR070291A1 (es) | AZAINDOL-3-CARBOXAMIDAS CíCLICAS, SU PREPARACIoN, SU USO COMO PRODUCTOS FARMACÉUTICOS Y SU EMPLEO EN LA FABRICACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR LA MODULACIoN DE RAS. | |
HRP20010845B1 (en) | Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives | |
HRP20020372B1 (en) | N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them | |
ATE246177T1 (de) | Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten | |
RU2015121347A (ru) | Производные, содержащие циклическую сульфонамидную группу, в качестве ингибиторов сигнального пути hedgenog | |
RS54001B1 (en) | SUBSTITUTED [(5H-Pyrrolo [2,1-C] [1,4] BENZODIAZEPIN-11-IL-) PIPERAZIN-1-IL] -2,2-DIMETHYLPROPANOIC ACID COMPOUNDS HT 2A | |
TH85621B (th) | อนุพันธ์เฮเมอโรแอริลเอธินิล, การผลิตและการใช้ในฐานะตัวกระทำทางเภสัชกรรมของสารนั้น | |
RU2005140090A (ru) | Способ синтеза гетероциклических соединений | |
TH88596B (th) | สารประกอบเคมี | |
TH120972B (th) | ซัลโฟนาไมด์ที่ถูกแทนที่ กระบวนการสำหรับการเตรียมของมัน องค์ประกอบทางเภสัชกรรมที่ประกอบรวมด้วยซัลโฟนาไมด์ดังกล่าวและการใช้ของมัน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
PNAN | Change of the applicant name, address/residence |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE |
|
A9IS | Complete republication of an hr-a document | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20140411 Year of fee payment: 15 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20150506 |